lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + triamcinolone

This drug is an unapproved **multi-component procedural combination kit** containing **lidocaine hydrochloride**, **bupivacaine hydrochloride**, **povidone-iodine**, and **triamcinolone** (typically **triamcinolone acetonide** in marketed kits). It is used in local or regional anesthesia and analgesia settings such as office-based injections and other interventional procedures. Lidocaine and bupivacaine are amide local anesthetics that block voltage-gated sodium channel conductance in peripheral nerves, reducing initiation and propagation of action potentials; lidocaine provides relatively rapid onset while bupivacaine provides longer duration. Triamcinolone is a glucocorticoid receptor agonist added for anti-inflammatory effect, and povidone-iodine is a topical antiseptic included for skin preparation rather than systemic pharmacologic activity. Publicly referenced examples include BLT-25 KIT and MLK F4 KIT listings on DailyMed/FDA, which identify these products as combination drug kits not found by FDA to be safe and effective under approved labeling. The product is best understood as a procedural anesthesia and injection kit rather than a uniquely developed therapeutic asset.

Brand names

BLT-25 KITBLT25 KITBLT 25 KITMLK F4 KIT

Other names

lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + triamcinolonebupivacaine hydrochloride + lidocaine hydrochloride + povidone-iodine + triamcinolone acetonide